Financhill
Back

AngioDynamics Quote, Financials, Valuation and Earnings

AngioDynamics Price Quote

$8.90
+0.01 (+3.73%)
(Updated: December 21, 2024 at 5:14 AM ET)

AngioDynamics Key Stats

Sell
49
AngioDynamics (ANGO) is a Sell

Day range:
$8.52 - $8.96
52-week range:
$5.26 - $9.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.23
P/B ratio:
1.84%

Volume:
567.9K
Avg. volume:
546.9K
1-year change:
18.06%
Market cap:
$361.2M
Revenue:
$303.9M
EPS:
$-4.57

How Much Does AngioDynamics Make?

Data Unavailable

Is AngioDynamics Growing As A Company?

Data Unavailable

AngioDynamics Stock Price Performance

  • Did AngioDynamics Stock Go Up Last Month?
    AngioDynamics share price went up by 31.9% last month
  • Did ANGO's Share Price Rise Over The Last Year?
    ANGO share price rose by 18.06% over the past 1 year

What Is AngioDynamics 52-Week High & Low?

AngioDynamics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AngioDynamics?

Data Unavailable

Is AngioDynamics Cash Flow Positive?

Data Unavailable

AngioDynamics Return On Invested Capital

Data Unavailable

AngioDynamics Earnings Date & Stock Price

  • What Is AngioDynamics's Stock Price Today?
    A single share of ANGO can be purchased today for 8.89
  • What Is AngioDynamics’s Stock Symbol?
    AngioDynamics trades on the nasdaq under the ticker symbol: ANGO
  • When Is AngioDynamics’s Next Earnings Date?
    The next quarterly earnings date for AngioDynamics is scheduled on January 3, 2025
  • When Is ANGO's next ex-dividend date?
    AngioDynamics's next ex-dividend date is December 22, 2024
  • How To Buy AngioDynamics Stock?
    You can buy AngioDynamics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AngioDynamics Competitors

  • Who Are AngioDynamics's Competitors?
    Below is a list of companies who compete with AngioDynamics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Globus Medical Inc (GMED)
    • Masimo Corp (MASI)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

AngioDynamics Dividend Yield

Data Unavailable

AngioDynamics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 64%
Revenue: -22.06% 0.18%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable